AQST

Aquestive Therapeutics INC

-$199.1M

Net Activity

Institutions Holding

174

Popularity Rank

#3228

Avg Weight

0.63%

Total Value

$278.1M

Ownership Trend

174 institutions currently hold AQST, with 101 net buyers and 99 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

99

Net Buying Institutions

101

Key Holders

View all 174 holding institutions

Quarterly Activity

Recent Activity

+$160.8M

Total Buy Value

$207.8M

Total Sell Value

New buy44
Trim48
Add57
Sold out51

101

Net Buyers

99

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

2

Filings (90d)

$222K

Total Est. Value

50K shares

Planned Shares

Last Filed 2026-06-23
FilerFiling DateEst. Value
Krop Julie2026-06-23$118K
Barber Daniel2026-06-15$104K

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding AQUESTIVE THERAPEUTICS INC (AQST)?
Major stakeholders currently include Bratton Capital Management, L.P. ($40.7M), BlackRock, Inc. ($31.2M), Rtw Investments, LP ($30.8M). Based on the latest 13F filings, there are a total of 174 tracked investment funds and institutions maintaining positions in AQST.
What is the overall institutional sentiment toward AQST recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $199.1M, driven by 101 managers accumulating shares while 99 reduced their exposure.
Which institutions have been selling or reducing their AQST positions?
In the latest period, 48 funds trimmed their holdings, and 51 managers completely exited their positions. The aggregate reported sell value was $207.8M.
Are there any notable investors adding AQST to their portfolios?
Yes, buying activity remains notable. 44 institutions opened new positions in {ticker}, and 57 existing holders added to their shares. The total reported buy value for the quarter amounted to $160.8M.

Related Stocks